South Dakota § 34-20B-17 Opiates included in Schedule II.

South Dakota Statutes

§ 34-20B-17 — Opiates included in Schedule II.

South Dakota § 34-20B-17

Title 34PUBLIC HEALTH AND SAFETY

Ch. 34-20DRUGS AND SUBSTANCES CONTROL

This text of South Dakota § 34-20B-17 (Opiates included in Schedule II.) is published on Counsel Stack Legal Research, covering South Dakota primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook

S.D. Codified Laws § 34-20B-17 (2026).

Text

Any of the following opiates, including their isomers, esters, ethers, salts, and salts of isomers, esters, and ethers, is included in Schedule II, unless specifically excepted, whenever the existence of such isomers, esters, ethers, and salts is possible within the specific chemical designation:

(1)Alphaprodine;

(2)Anileridine;

(3)Bezitramide;

(4)Diphenoxylate;

(5)Fentanyl;

(6)Isomethadone;

(7)Levomethorphan;

(8)Levorphanol;

(9)Metazocine;

(10)Methadone;

(11)Methadone-intermediate, 4-cyano-2-dimethylamine-1, 4-diphenyl butane;

(12)Moramide-intermediate, 2-methyl-3-morpholino-1, 1-diphenylpropane-carboxylic acid;

(13)Pethidine;

(14)Pethidine-intermediate, A, 4-cyano-1-methyl-4-phenylpiperidine;

(15)Pethidine-intermediate, B, ethyl

Free access — add to your briefcase to read the full text and ask questions with AI

Any of the following opiates, including their isomers, esters, ethers, salts, and salts of isomers, esters, and ethers, is included in Schedule II, unless specifically excepted, whenever the existence of such isomers, esters, ethers, and salts is possible within the specific chemical designation: (1) Alphaprodine; (2) Anileridine; (3) Bezitramide; (4) Diphenoxylate; (5) Fentanyl; (6) Isomethadone; (7) Levomethorphan; (8) Levorphanol; (9) Metazocine; (10) Methadone; (11) Methadone-intermediate, 4-cyano-2-dimethylamine-1, 4-diphenyl butane; (12) Moramide-intermediate, 2-methyl-3-morpholino-1, 1-diphenylpropane-carboxylic acid; (13) Pethidine; (14) Pethidine-intermediate, A, 4-cyano-1-methyl-4-phenylpiperidine; (15) Pethidine-intermediate, B, ethyl-4-phenylpiperidine-4-carboxylate; (16) Pethidine-intermediate, C, 1-methyl-4-phenylpiperidine-4-carboxylic acid; (17) Phenazocine; (18) Piminodine; (19) Racemethorphan; (20) Racemorphan; (21) Sufentanil; (22) Alfentanil; (23) Carfentanil; (24) Levo-alphacetylmethadol, also known as levo-alpha-acetylmethadyl acetate or LAAM; (25) Remifentanil; (26) Oxymorphone; (27) Oripavine (3-O-demethylthebaine or 6,7,8,14-tetradehydro-4,5-alpha-epoxy-6-methoxy-17-methylmorphinan-3-ol); (28) 4-anilino-N-phenethylpiperidine (ANPP); (29) Morphine, except when it meets subdivision 34-20B-23 (8); (30) Hydrocodone (Dihydrocodeinone); (31) Codeine, except when it meets subdivision 34-20B-23 (1), 34-20B-23 (2), or 34-20B-26 (1); (32) Dihydrocodeine, except when it meets subdivision 34-20B-23 (5) or 34-20B-26 (2); (33) Ethylmorphine, except when it meets subdivision 34-20B-23 (6) or 34-20B-26 (3); (34) Oxycodone; (35) Hydromorphone; (36) Thiafentanil; (37) Noroxymorphone; (38) N-phenyl-N-(piperidin-4-yl)propionamide (norfentanyl); and (39) Oliceridine (N-[(3-methoxythiophen-2-yl)methyl] ({2-[(9R)-9-(pyridin-2-yl)-6-oxaspiro [4.5]decan-9-yl]ethyl})amine fumarate).

Legislative History

SL 1970, ch 229, § 8 (b) (1); SDCL Supp, § 39-17-60; SL 1985, ch 278, § 52; SL 1987, ch 255, § 4; SL 1989, ch 293, § 3; SL 1994, ch 278, § 3; SL 2002, ch 167, § 1; SL 2007, ch 194, § 1, eff. Feb. 1, 2007; SL 2008, ch 170, § 2, eff. Feb. 13, 2008; SL 2011, ch 160, § 2, eff. Feb. 24, 2011; SL 2015, ch 180, § 3, eff. Feb. 18, 2015; SL 2017, ch 156, § 2, eff. Feb. 3, 2017; SL 2020, ch 144, § 2, eff. Mar. 9, 2020; SL 2021, ch 144, § 5, eff. Feb. 17, 2021.